Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Hendrik Feys

64 Results

2023

Single step method for high yield human platelet lysate production

Veerle CompernolleHendrik Feys

A1 Journal Article in TRANSFUSION

2022

ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation

A1 Journal Article in JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Multinational analysis of children transfused with pathogen inactivated platelets

A2 Journal Article in HOSPITAL PEDIATRICS

2021

A novel competition ELISA for the rapid quantification of SARS-CoV-2 neutralizing antibodies in convalescent plasma

Caro VerbruggheVeerle CompernolleHendrik Feys

A1 Journal Article in TRANSFUSION

Determination of anti‐ADAMTS13 autoantibody titers in ELISA : influence of ADAMTS13 presentation and autoantibody detection

A1 Journal Article in JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation : a brief commentary

Editorial material

Immunogenic hotspots in the spacer domain of ADAMTS13 in immune‐mediated thrombotic thrombocytopenic purpura

A1 Journal Article in JOURNAL OF THROMBOSIS AND HAEMOSTASIS

SARS-CoV-2 neutralising antibody testing in Europe : towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data

A1 Journal Article in EUROSURVEILLANCE

The need for and challenges of comparing SARS-CoV-2 antibody assays

Editorial material

Tuning the surface interactions between single cells and an OSTE+ microwell array for enhanced single cell manipulation

A1 Journal Article in ACS APPLIED MATERIALS & INTERFACES

2020

Innovations in platelet transfusion medicine

Katrijn SixHendrik FeysVeerle CompernolleKatrien Devreese

Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura

A1 Journal Article in BLOOD

Platelet Biochemistry and Morphology after Cryopreservation

Katrijn SixHendrik FeysVeerle Compernolle

A1 Journal Article in International Journal of Molecular Sciences

The senotherapeutic nicotinamide riboside raises platelet nicotinamide adenine dinucleotide levels but cannot prevent storage lesion

Veerle CompernolleHendrik Feys

A1 Journal Article in TRANSFUSION

When platelets are left in the cold

Katrijn SixVeerle CompernolleHendrik Feys

A2 Journal Article in ANNALS OF BLOOD

2019

A comparison of haematopoietic stem cells from umbilical cord blood and peripheral blood for platelet production in a microfluidic device

Katrijn SixHendrik FeysVeerle Compernolle

A1 Journal Article in VOX SANGUINIS

Biomolecular consequences of platelet pathogen inactivation methods

Hendrik FeysVeerle Compernolle

A1 Journal Article in TRANSFUSION MEDICINE REVIEWS

Impact of cold storage on platelets treated with Intercept pathogen inactivation

Katrijn SixVeerle CompernolleHendrik Feys

A1 Journal Article in TRANSFUSION

The ice recrystallization inhibitor polyvinyl alcohol does not improve platelet cryopreservation

Katrijn SixVeerle CompernolleHendrik Feys

A1 Journal Article in TRANSFUSION

2018

Comparison between manufacturing sites shows differential adhesion, activation, and GPIbα expression of cryopreserved platelets

Katrijn SixKatrien DevreeseVeerle CompernolleHendrik Feys

A1 Journal Article in TRANSFUSION

Comparison of three commercially available buffy coat pooling sets for the preparation of platelet concentrates

Hendrik FeysVeerle Compernolle

A1 Journal Article in VOX SANGUINIS

Major changes of von Willebrand factor multimer distribution in cirrhotic patients with stable disease or acute decompensation

A1 Journal Article in THROMBOSIS AND HAEMOSTASIS

2017

A microfluidic flow chamber model for platelet transfusion and hemostasis measures platelet deposition and fibrin formation in real-time

Katrijn SixPhilippe VandekerckhoveHendrik FeysVeerle Compernolle

A1 Journal Article in JOVE-JOURNAL OF VISUALIZED EXPERIMENTS

High platelet content can increase storage lesion rates following Intercept pathogen inactivation primarily in platelet concentrates prepared by apheresis

Hendrik FeysVeerle Compernolle

A1 Journal Article in VOX SANGUINIS

2016

Microfluidic flow chambers using reconstituted blood to model hemostasis and platelet transfusion in vitro

Hendrik FeysPhilippe VandekerckhoveVeerle Compernolle

A1 Journal Article in JOVE-JOURNAL OF VISUALIZED EXPERIMENTS

Persistent aggregates in apheresis platelet concentrates are commonly collected from donors with a history of aggregate donation

Hendrik FeysPhilippe VandekerckhoveVeerle Compernolle

A1 Journal Article in VOX SANGUINIS

Psoralen and ultraviolet A light treatment directly affects phosphatidylinositol 3-kinase signal transduction by altering plasma membrane packing

Philippe VandekerckhoveVeerle CompernolleHendrik Feys

A1 Journal Article in JOURNAL OF BIOLOGICAL CHEMISTRY

The contribution of von Willebrand factor-GPIbα interactions to persistent aggregate formation in apheresis platelet concentrates

Hendrik FeysPhilippe VandekerckhoveVeerle Compernolle

A1 Journal Article in VOX SANGUINIS

2015

Aggregates in platelet concentrates

Hendrik FeysVeerle Compernolle

A1 Journal Article in VOX SANGUINIS

Linker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS-13

A1 Journal Article in JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Observational study of corrected count increments after transfusion of platelets treated with riboflavin pathogen reduction technology in additive solutions

A1 Journal Article in TRANSFUSION

Persistent aggregates in apheresis platelet concentrates

Hendrik FeysPhilippe VandekerckhoveVeerle Compernolle

A1 Journal Article in VOX SANGUINIS

Riboflavin and amotosalen photochemical treatments of platelet concentrates reduce thrombus formation kinetics in vitro

Hendrik FeysPhilippe VandekerckhoveVeerle Compernolle

A1 Journal Article in VOX SANGUINIS

Ultraviolet C light pathogen inactivation treatment of platelet concentrates preserves integrin activation but affects thrombus formation kinetics on collagen in vitro

Philippe VandekerckhoveVeerle CompernolleHendrik Feys

A1 Journal Article in TRANSFUSION

2014

Allosteric activation of ADAMTS13 by von Willebrand factor

A1 Journal Article in PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion

Hendrik FeysKatrien DevreesePhilippe VandekerckhoveVeerle Compernolle

A1 Journal Article in VOX SANGUINIS

Paired analysis of plasma proteins and coagulant capacity after treatment with three methods of pathogen reduction

Katrien DevreeseHendrik FeysPhilippe VandekerckhoveVeerle Compernolle

A1 Journal Article in TRANSFUSION

Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy

Hendrik FeysPhilippe VandekerckhoveVeerle Compernolle

A1 Journal Article in TRANSFUSION

2013

Nitric oxide levels increase during platelet concentrate production from buffy coats, but not during storage

Hendrik FeysPhilippe VandekerckhoveVeerle Compernolle

A1 Journal Article in TRANSFUSION

2012

Blood platelet biochemistry

A1 Journal Article in THROMBOSIS RESEARCH

Inhibition of von Willebrand factor-platelet glycoprotein Ib interaction prevents and reverses symptoms of acute acquired thrombotic thrombocytopenic purpura in baboons

A1 Journal Article in BLOOD

2011

Local elongation of endothelial cell-anchored von Willebrand factor strings precedes ADAMTS13 protein-mediated proteolysis

A1 Journal Article in JOURNAL OF BIOLOGICAL CHEMISTRY

Platelets at work in primary hemostasis

A1 Journal Article in BLOOD REVIEWS

Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain

A1 Journal Article in HAEMATOLOGICA-THE HEMATOLOGY JOURNAL

2010

Active platelet-binding conformation of plasma von Willebrand factor in young women with acute myocardial infarction

A1 Journal Article in JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Inactivation of ADAMTS13 by plasmin as a potential cause of thrombotic thrombocytopenic purpura

A1 Journal Article in JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet-decorated VWF strings in vivo

A1 Journal Article in JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus)

A1 Journal Article in BLOOD

2009

ADAMTS13 in health and disease

A1 Journal Article in ACTA HAEMATOLOGICA

ADAMTS13's tail tale

Editorial material

Multi-step binding of ADAMTS-13 to von Willebrand factor

A1 Journal Article in JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Mutation of the H-bond acceptor S119 in the ADAMTS13 metalloprotease domain reduces secretion and substrate turnover in a patient with congenital thrombotic thrombocytopenic purpura

A1 Journal Article in BLOOD

2008

ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission

A1 Journal Article in HAEMATOLOGICA-THE HEMATOLOGY JOURNAL

Inherited traits affecting platelet function

A1 Journal Article in BLOOD REVIEWS

2007

ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis

A1 Journal Article in BRITISH JOURNAL OF HAEMATOLOGY

Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure

A1 Journal Article in CRITICAL CARE MEDICINE

Factor XI/ADAMTS13 complexes are quantitatively insignificant in human plasma

A1 Journal Article in HAEMATOLOGICA-THE HEMATOLOGY JOURNAL

2006

ADAMTS-13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences

A1 Journal Article in JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Alteration of ADAMTS13 antigen levels in patients with idiopathic thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura and systemic lupus erythematosus

A1 Journal Article in THROMBOSIS AND HAEMOSTASIS

Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs

A2 Journal Article in CARDIOVASCULAR & HEMATOLOGICAL DISORDERS. DRUG TARGETS

Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13

A1 Journal Article in BLOOD

[A clinical study of congenital thrombotic thrombocytopenic purpura]

A2 Journal Article in ZHONGHUA NEI KE ZA ZHI = CHINESE JOURNAL OF INTERNAL MEDICINE

[Determination of the ADAMTS13 antigen and its activity in TTP patients and carriers]

A2 Journal Article in ZHONGHUA XUEYEXUE ZAZHI = CHINESE JOURNAL OF HEMATOLOGY

2004

Monoclonal antibody IAC-1 is specific for activated α2β1 and binds to amino acids 199 to 201 of the integrin α2 I-domain

A1 Journal Article in BLOOD